Asia-Pacific Americas Africa Europe Middle East

PAKISTAN FEROZSONS LABORATORIES LTD

Company Profile:

It is a factory (manufacturer).

PAKISTAN FEROZSONS LABORATORIES LTD is a prominent pharmaceutical manufacturing company based in Pakistan. Established in 1954, it has grown to be one of the country's leading and most respected pharmaceutical enterprises. The company specializes in the manufacturing, marketing, and distribution of a diverse portfolio of pharmaceutical products, including ethical (prescription) drugs, over-the-counter medications, and various healthcare solutions.

Ferozsons operates state-of-the-art manufacturing facilities that meet international quality benchmarks, including Good Manufacturing Practices (GMP). It is deeply committed to innovation, research and development, and frequently collaborates with international pharmaceutical companies through licensing and partnership agreements to introduce advanced medical therapies to the local and regional markets. The company's mission is to enhance patient health and well-being by providing high-quality, accessible, and affordable medicines. It is also a publicly listed company on the Pakistan Stock Exchange.

Enterprise Products

Ferozsons Laboratories Ltd. Pakistan manufactures and/or markets the following:

* **Gastrointestinal:** Cremaffin, Duphalac, Entamizole, Flagyl, Lactulose

* **Cardiovascular:** Cardiovasc, Dilzem, Isordil, Natrilix

* **Anti-infectives:** Norflox, Zinnat

* **Respiratory:** Mucogel

* **Neurology:** Frisium

* **Hepatology:** Silybon

* **Oncology:** Endoxan

* **Vaccines:** Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)

* **Hormonal therapy:** Duphaston

* **Other:** Dexorange, Osnate

Business Registration Information:

Manager:

Osman Khalid Waheed (CEO and Managing Director)

Phone:

+92 (42) 111 33769

E-mail:

info@ferozsons.com

Official Website:
Address:

197-A, Shahrah-e-Qaid-e-Azam, Lahore 54000, Pakistan

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.